Plasma

2020 Surveillance Report shows blood supply remained above target in first year of pandemic


Thursday, September 16, 2021
Canadian Blood Services recently published its annual Surveillance Report, a summary of monitoring efforts related to transmissible infection testing in donors; possible transfusion-transmitted infections in recipients; and new, emerging pathogens. Surveillance also includes monitoring of donor safety.

Mapping convalescent plasma distribution with Canadian Blood Services funding


Thursday, July 15, 2021
Dr. Andrew Shih recently received funding from the Centre for Innovation to process map the implementation of the CONCOR-1 convalescent plasma trials in British Columbia – work that may inform and improve future clinical trials. Dr. Shih talks to Massimo Cau, a PhD Candidate at the Centre for Blood Research, about his research plans.

Diverse talks that informed and inspired – Norman Bethune Symposium 2021


Friday, July 09, 2021
Postdoctoral fellow, Dr. Basit Yousuf, describes his experience attending and presenting at the 10th annual Norman Bethune Symposium.

Laying the groundwork for a more inclusive blood system


Thursday, June 24, 2021
Dr. Catherine Jenkins, scientist and LGBTQ+ advocate, is part of our effort to evolve donor screening questions.

The impact of COVID-19 on blood donation in Canada


Tuesday, May 25, 2021
An article recently published on the Canadian Blood Services’ professional education website looks back on the impact of the pandemic on blood donation in Canada.

Centre for Innovation: Funding award updates and open competitions


Thursday, May 13, 2021
Through the Centre for Innovation’s competitive funding programs, Canadian Blood Services conducts and supports researchers and research projects in key areas. Recipients for one of our most dynamic programs, the BloodTechNet Award, were recently announced, and several other funding opportunities are now open for applications.

Improving patient safety: preventing a harmful side effect of IVIg treatment


Friday, April 09, 2021
Our research is improving patient safety for those who need intravenous immune globulin (IVIg), a drug used to treat autoimmune diseases. By increasing our understanding of an unexpected, potentially life-threatening side effect of IVIg therapy, our studies can help doctors better predict which patients are most at risk and take steps to protect them.

The Canadian Blood Services Lifetime Achievement Award 2021: Nominations now open


Tuesday, April 06, 2021
The Canadian Blood Services Lifetime Achievement Award recognizes individuals whose landmark contributions are both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad.

2020: The year no one expected - Challenges researchers face during a global pandemic


Thursday, April 01, 2021
Sarah Longo’s personal and engaging story describing the challenges she faced starting a new research position in the middle of the pandemic was awarded runner up in this year’s Lay Science Writing Competition.

Lost in lab: deciphering blood immune cells to fight COVID-19


Tuesday, March 23, 2021
We are delighted to publish the entries that were awarded joint first place in this year’s Lay Science Writing Competition. Read on for Melina Messing’s sobering but ultimately hopeful entry describing her experiences as a immunology researcher during the pandemic.